The Forefront of Infection Prevention

A Scientific Collaboration

This revolutionary polymer is the result of a scientific collaboration between Research Scientist Joseph Sant'Angelo, and NYU Professor of Dermatology Dr. Perry Robins

proprietary method of action

KILLS pathogens

Preventogen actively kills viruses, fungi and bacteria on contact by lysing the cell surface leading to quick cell death

SEALS

The liquid dries, creating a clear, biodegradable, odorless and elastomeric film barrier

PROTECTS

The flexible film barrier protects the wound from water, dirt and oxygen

Provides an optimal healing environment

The carbon dioxide that is infused into Preventogen during the manufacturing process is released, lowering the pH of the wound bed which helps to promote healing

ideal for patients at risk of infection

Preventogen is ideal for patients with an increased risk of infection or minor wound progression

Common risk factors associated with poor healing include: trauma, compromised immune system, diabetes, poor circulation, inflammation, stress or poor nutritional status

Non-flammable

Preventogen is non-flammable and safe to use in operating rooms

proven to kill on contact

Preventogen has been proven to eradicate the CDC's most serious threats on contact

BACTERIA

Acinetobacter baumanii (multi-antibiotic resistant)

Campylobacter jejuni (drug-resistant)

Clostridioides difficile

Carbapenem-resistant Enterobacter cloacae

Cutibacterium acnes (Propionibacterium acnes) 

Enterococcus faecalis (drug-resistant)

Escherichia coli

MRSA: Methicillin-resistant Staphylococcus aureus

Mycobacterium avium

Neisseria gonorrhoeae (drug-resistant)

Pseudomonas aeruginosa

Shigella flexneri

Staphylococcus aureus

Streptococcus pneumoniae (drug-resistant)

Streptococcus pyogenes

VRE: Vancomycin-resistant Enterococci

FUNGI

Aspergillus brasiliensis

Candida albicans (drug-resistant)

Candida auris (antibiotic resistant)

Trichophyton mentagrophytes

Trichophyton rubrum

VIRUS

Herpes Simplex Virus Type 1

Monkeypox Virus (USA-2003)

Varicella Zoster Virus

Serious or Urgent threats as cited in the CDC’s Antibiotic Resistance Threats in the United States, 2019

Newest data